Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2013 Apr 22;2013:bcr2013008643. doi: 10.1136/bcr-2013-008643

Prostate carcinoma presenting with bulky mediastinal and cervical lymphadenopathy

Jocelyn Tan-Shalaby 1
PMCID: PMC3645396  PMID: 23608847

Description

A 65-year-old Caucasian man with a high-risk prostatic carcinoma metastatic to the bones and regional pelvic nodes received palliative radiotherapy followed by combined hormonal therapy with leuprolide and bicalutamide only to rapidly progress in a bulky left-sided cervical and mediastinal adenopathy (figures 13). Cervical node biopsy was positive for a metastatic prostate carcinoma. He was offered docetaxel and prednisone and experienced a significant decrease in all areas of lymphadenopathy after six cycles and normalisation of his prostate-specific antigen levels (figures 2 and 4).

Figure 1.

Figure 1

Enlarged cervical adenopathy prior to docetaxel prednisone chemotherapy.

Figure 2.

Figure 2

Cervical adenopathy responding to docetaxel prednisone chemotherapy.

Figure 3.

Figure 3

Mediastinal lymphadenopathy prior to docetaxel prednisone chemotherapy.

Figure 4.

Figure 4

Mediastinal lymphadenopathy after docetaxel prednisone chemotherapy.

A supraclavicular or mediastinal presentation in prostate cancer is rare and is usually mistaken for upper aerodigestive or head and neck tumours, and in this case, a lymphoma. When present, cervical nodes are usually left sided though rarely right-sided nodes have also been reported.1 2 Access of the tumour cells occur via local spread in the iliac and paraaortic nodes, which then drain into the cisterna chyli, the sac-like structure of the lymphatic system which is located behind the stomach. Cancer cells can then make their way up the lymphatic path, draining into the thoracic duct, and finally into the left subclavian vein.2

Diagnostic investigations are usually directed to non-prostatic sites and treatment is subsequently delayed.

Although distant metastasis in prostate cancer usually suggests a grim prognosis, several cases of prostate cancer spreading to cervical and mediastinal nodes treated with conventional treatment have resulted in complete and durable remission.3

Treatment approach for these patients should be the same as for prostate cancer presenting with bony or visceral metastases.

Learning points.

  • Cervical adenopathy when present in prostate cancer is usually left sided, although right-sided cases can also rarely occur.

  • Therapy should be similar to that of prostate cancer presenting with bony or visceral metastasis.

  • Despite the presence of distal nodal spread, patients in good performance status should be offered conventional treatment because these cases can still achieve excellent and durable responses.

Footnotes

Competing interests: None.

Patient consent: Obtained.

Provenance and peer review: Not commissioned; externally peer reviewed.

References

  • 1.Jones H, Anthony PP. Metastatic prostatic carcinoma presenting as left sided cervical lymphadenopathy: a series of 11 cases. Histopathology 1992;2013:149–54 [DOI] [PubMed] [Google Scholar]
  • 2.Wang HJ, Chiang PH, Peng JP, et al. Presentation of prostate carcinoma with cervical lymphadenopathy: report of three cases. Chang Gung Med J 2004;2013:840–4 [PubMed] [Google Scholar]
  • 3.Tsuzuki M, Kawakami S, Yonese J, et al. A case of completely responding stage D2 prostatic cancer with no evidence of disease 14 years after diagnosis (Article in Japanese). Hinyokika Kiyo 1994;2013:837–40 [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES